DocGo Inc. (DCGO)
| Market Cap | 17.37M -83.4% |
| Revenue (ttm) | 297.34M -19.2% |
| Net Income | -181.25M |
| EPS | -1.84 |
| Shares Out | 98.99M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 555,800 |
| Open | 0.1836 |
| Previous Close | 0.1832 |
| Day's Range | 0.1751 - 0.1950 |
| 52-Week Range | 0.1751 - 1.1000 |
| Beta | 1.00 |
| Analysts | Buy |
| Price Target | 1.38 (+683.48%) |
| Earnings Date | Nov 9, 2026 |
About DCGO
DocGo Inc. operates as a mobile healthcare services company in the United States and the United Kingdom. It operates through Mobile Health Services and Transportation Services segments. The company offers transportation services comprising emergency response services; and non-emergency transport services, such as ambulance and wheelchair transportation services. It also provides mobile health services through its care delivery platform that are performed at home, offices, and other locations comprising mobile urgent care, exams, vaccinations, m... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 5 analysts, the average rating for DCGO stock is "Buy." The 12-month stock price target is $1.38, which is an increase of 683.48% from the latest price.
News
DocGo board begins search for new CEO
DocGo (DCGO) announced that the Board has begun a comprehensive search to identify the next CEO, as Bienstock’s employment contract expires on December 31, 2026. Bienstock will continue as CEO…
DocGo reports Q3 EPS (17c), consensus (40c)
Reports Q3 revenue $73.4M, consensus $77.25M. Lee Bienstock, Chief Executive Officer of DocGo (DCGO) commented, “We remain firmly committed to our goal of exiting the year at a profitable run…
DocGo price target lowered to $1 from $3 at Needham
Needham lowered the firm’s price target on DocGo (DCGO) to $1 from $3 and keeps a Buy rating on the shares. The company reported a mixed quarter, with adjusted EBITDA…
DocGo Earnings Call Transcript: Q3 2026
Q3 revenue increased YoY and adjusted EBITDA loss narrowed as margins improved and costs fell. FY2026 revenue guidance was lowered, while adjusted EBITDA guidance was maintained and management expects positive adjusted EBITDA in 2027.
DocGo Earnings release: Q3 2026
DocGo released its Q3 2026 earnings on November 9, 2026, summarizing the period's financial results.
DocGo Quarterly report: Q3 2026
DocGo has published its Q3 2026 quarterly earnings report on November 9, 2026.
DocGo Announces Third Quarter 2026 Results and CEO Transition
NEW YORK--(BUSINESS WIRE)--DocGo Announces Q3 2026 Results and CEO Transition. Gross Margin Improves 280 Basis Points Over Q2 Due to Company Profitability Initiatives.
DocGo to Announce Third Quarter 2026 Results on Monday, November 9, 2026
NEW YORK--(BUSINESS WIRE)--DocGo to Announce Third Quarter 2026 Results on Monday, November 9, 2026. Management to host conference call and webcast at 5:00 p.m. ET on that day.
DocGo Transcript: Investor update
Revised summary: The acquisition of Hicuity Health will create a vertically integrated care platform, combining virtual acute care, mobile health, and remote monitoring. Integration aims for operational efficiencies, technology unification, cross-selling, $4.3M in annual cost savings, profitable growth, and expanded patient access.
DocGo Slides: Investor update
DocGo has posted slides in relation to its latest quarterly earnings report, which was published on September 29, 2026.
DocGo Announces Upcoming Webinar to Outline Vision and Details of the Pending Hicuity Health Acquisition
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health and medical transportation services, announced today that Lee Bienstock, Chief Ex...
DocGo Transcript: Morgan Stanley 24th Annual Global Healthcare Conference
Mobile health and medical transportation services are expanding through tech-driven efficiency, targeted M&A, and a focus on outcomes-based care. Profitability is targeted by year-end via margin improvement, cost reduction, and portfolio optimization, with new acquisitions like Hicuity Health enhancing the care continuum.
DocGo Slides: Investor presentation
DocGo has posted slides in relation to its latest quarterly earnings report, which was published on September 7, 2026.
DocGo Announces Upcoming Participation at Morgan Stanley 24th Annual Global Healthcare Conference
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health and medical transportation services, announced today that Lee Bienstock, Chief Ex...
DocGo Earnings Call Transcript: Q2 2026
Q2 2026 saw record volumes in core business lines, a major acquisition (Hicuity Health), and new funding, despite a year-over-year revenue decline due to the wind-down of migrant projects. Adjusted EBITDA loss improved sequentially, and full-year guidance was narrowed, with positive EBITDA run rate expected by year-end.
DocGo Earnings release: Q2 2026
DocGo released its Q2 2026 earnings on August 17, 2026, summarizing the period's financial results.
DocGo Quarterly report: Q2 2026
DocGo has published its Q2 2026 quarterly earnings report on August 17, 2026.
DocGo enters agreement to acquire Hicuity Health
DocGo (DCGO) has entered into a definitive agreement to acquire 100% of virtual care provider, Hicuity Health. DocGo is acquiring Hicuity in exchange for the assumption of the company’s existing…
DocGo reports Q2 EPS (16c), consensus (36c)
Reports Q2 revenue $73.4M, consensus $75.57M. “The continued evolution of our company into the premier provider of virtual, remote, and in-home healthcare at any address took a major leap forward…
DocGo narrows FY26 revenue view to $305M-$310M from $300M-$315M
Consensus $305.12M. Guidance does not include any contribution from the acquisition of Hicuity Health, as the transaction has not yet closed.
DocGo Announces Second Quarter 2026 Results
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial a...
DocGo to Announce Second Quarter 2026 Results on Monday, August 17, 2026
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, announced today that the Co...
Did DocGo Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...
DocGo Transcript: AGM 2026
The meeting covered board transitions, approval of key proposals, and strong financial performance, including record growth in core business lines and successful acquisitions. Strategic initiatives focus on technology-driven efficiency and integrated care, with ongoing exploration of shareholder value alternatives.
DocGo Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026
The business has shifted from emergency response to a scalable, technology-driven healthcare delivery model, focusing on in-home, virtual, and transportation services. Integration of SteadyMD and the Care Anywhere platform is driving efficiency, margin improvement, and growth, while regulatory changes and payer partnerships support a path to profitability and long-term expansion.